Deutsche Bank’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Buy
57,713
+3,738
+7% +$17.8K ﹤0.01% 3200
2026
Q1
$281K Buy
53,975
+28,879
+115% +$171K ﹤0.01% 2854
2025
Q4
$134K Buy
+25,096
New +$140K ﹤0.01% 3202
2025
Q3
Sell
-33,982
Closed -$103K 3731
2025
Q2
$103K Buy
+33,982
New +$117K ﹤0.01% 3243
2021
Q2
Sell
-2,480
Closed -$39K 4788
2021
Q1
$39K Sell
2,480
-234
-9% -$4.34K ﹤0.01% 4288
2020
Q4
$66K Buy
2,714
+1,688
+165% +$36.4K ﹤0.01% 4038
2020
Q3
$17K Buy
1,026
+98
+11% +$2.27K ﹤0.01% 4138
2020
Q2
$27K Buy
+928
New +$28.7K ﹤0.01% 4005
2018
Q4
Sell
-1,073
Closed -$84K 5408
2018
Q3
$84K Buy
1,073
+163
+18% +$15K ﹤0.01% 4562
2018
Q2
$89K Buy
+910
New +$84.8K ﹤0.01% 4590
2016
Q3
Sell
-161
Closed -$51K 5187
2016
Q2
$51K Sell
161
-3
-2% -$897 ﹤0.01% 4400
2016
Q1
$49K Buy
164
+116
+242% +$37.4K ﹤0.01% 4328
2015
Q4
$29K Sell
48
-5
-9% -$2.93K ﹤0.01% 4633
2015
Q3
$29K Buy
53
+7
+15% +$4.33K ﹤0.01% 4660
2015
Q2
$33K Buy
+46
New +$28.5K ﹤0.01% 4751
2015
Q1
Sell
-214
Closed -$89K 5883
2014
Q4
$89K Buy
+214
New +$86.3K ﹤0.01% 4794

Other funds holding TARA

Deutsche Bank's TARA Position: Q2 2026 in Review

Deutsche Bank increased its Protara Therapeutics (TARA) stake by 6.9% in Q2 2026, buying an estimated $17.8K and bringing the position to 57,713 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #3200.

Deutsche Bank first reported a position in TARA in Q4 2014 and has held it in 16 quarters since. The position peaked at $281K in Q1 2026. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Deutsche Bank held 57,713 shares of Protara Therapeutics worth $220K as of Q2 2026.
  • Deutsche Bank bought 3,738 Protara Therapeutics shares in Q2 2026, an estimated $17.8K.
  • Protara Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3200 holding.
  • Deutsche Bank first reported a position in Protara Therapeutics in Q4 2014 and has held it in 16 quarters since.
  • Deutsche Bank's Protara Therapeutics position peaked at $281K in Q1 2026.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.